The U.K.’s Department for International Development (DFID) on Saturday said it might reduce its contribution to the U.N. Food and Agriculture Organization (FAO) if the agency does not improve its performance, Reuters reports. According to a DFID review, “FAO’s performance is patchy, particularly at country level, and that reforms need to be prioritised.”
Private Sector Involvement
New Resources On Federal Global Health, HIV/AIDS Budgets: The Kaiser Family Foundation has released a collection of new resources examining global health and HIV/AIDS funding in the Obama administration’s FY12 budget proposal. A new fact sheetÂ breaks down the $9.8 billion budget request for the Global Health Initiative (GHI), a six-year,…
New Strategies To Improve Developing Countries’ Access To Low-Cost Generic Drugs Needed, Experts Say
New strategies that ensure developing countries have access to low-cost generic medicines and encourage innovation are needed, according to experts who attended a recent meeting sponsored by the WHO, World Intellectual Property Organization, and World Trade Organization (WTO) that addressed growing concern that strict intellectual property protections are limiting access to low-cost generic medicines, BMJ News reports.
The U.N. on Friday said Haiti’s cholera outbreak appears to be waning overall, but high death rates from the virus in rural regions of the country remain a concern, the Associated Press reports. According to figures released by the Haitian government, 231,070 cholera cases and 4,549 deaths from the disease have been reported since the outbreak first emerged in October.
Factors Contributing to HealthÂ Of Women Worldwide: The Kaiser Family Foundation features a narrated slide tutorial by epidemiologist Laurel Spielberg on the health issues facing women around the world. The tutorial touches on issues such as economic status and biological, social, and cultural factors that affect women’s health, as well as…
“A rise in global funding for research into neglected diseases needs to be matched by a continued focus on delivering practical new ways to curb sickness in the developing world,” according to the third annual report by the Global Funding of Innovation for Neglected Diseases (G-FINDER) released on Wednesday, Reuters reports.
On Monday, the same day the GAVI Alliance helped oversee the roll out of a routine pneumococcal vaccine in Kenya, GAVI chairman Dagfinn Hoybraten highlighted the need for greater reductions in vaccine prices in developing countries during an interview with Reuters, the news service reports. The piece examines the funding mechanism in place to finance the pneumococcal vaccines, known as Advance Market Commitment (AMC), as well as the budget shortfall facing the group (Kelland, 2/14).
Stockpiling Flu Drugs, Vaccines Reduces Impact Of Pandemic, But Option Out Of Reach For Most Countries, Study Finds
“Stockpiling antiviral flu drugs and vaccines saves lives and reduces disease in a flu pandemic,” but the cost to maintain such a stockpile and deploy interventions in the event of an outbreak “is too expensive for around two thirds of the world’s population, scientists said on Wednesday,” Reuters reports.
Also In Global Health News: Reproductive Health In Philippines; Microfinance Debt In India; HIV/AIDS In Kenya; Google’s DotOrg
Reproductive Health Bill Is Approved By Philippines House Of Representatives IRIN reports a “hotly debated”Â bill “that proposes national funding for, and access to, reproductive healthcare services and products,” cleared “a major hurdle on [Monday] after being approved by a committee of the Philippines House of Representatives” (2/1). Biliran Rep. Rogelio…
Johnson & Johnson’s Tibotec Pharmaceuticals unit on Thursday announced it granted multiple licenses to generic drug manufacturers” to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if itâ€™s approved by regulators,” Bloomberg Businessweek reports.